CAS: 2412270-22-3
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
CA77.1 REF: AN-AG01V3JQCAS: 2412270-22-3 | 98% | To inquire | Mon 13 May 24 | |
CA77.1 [CMA Activator] REF: 7W-GW5222CAS: 2412270-22-3 | - - - | 143.00 €~428.00 € | Tue 21 May 24 | |
CA77.1 REF: TM-T9062CAS: 2412270-22-3 | 98.85% | 57.00 €~380.00 € | Tue 21 May 24 | |
Ca77.1 REF: 3D-MWD27022CAS: 2412270-22-3 | Min. 95% | To inquire | Tue 25 Jun 24 |
Ref: AN-AG01V3JQ
50mg | 565.00 € | |
100mg | To inquire | |
250mg | To inquire |
Estimated delivery in United States, on Monday 13 May 2024
CA77.1
CAS:2412270-22-3
CA77.1(CA) is a novel chaperon-mediated autophagy (CMA) activator for the treatment of Alzheimer's disease (AD).
Formula:
C16H12ClN3O
Purity:
98.85%
Color and Shape:
Solid
Molecular weight:
297.74
Ref: TM-T9062
5mg | 57.00 € | |
10mg | 92.00 € | |
25mg | 161.00 € | |
50mg | 245.00 € | |
100mg | 380.00 € | |
1ml*10 (DMSO) | 63.00 € |
Estimated delivery in United States, on Tuesday 21 May 2024
Ca77.1
CAS:2412270-22-3
Please enquire for more information about Ca77.1 including the price, delivery time and more detailed …
Formula:
C16H12ClN3O
Purity:
Min. 95%
Molecular weight:
297.74 g/mol
Ref: 3D-MWD27022
5mg | To inquire | |
10mg | To inquire | |
25mg | To inquire | |
50mg | To inquire | |
100mg | To inquire |
Estimated delivery in United States, on Tuesday 25 Jun 2024